Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 150,000 shares at $20.08 ($3.0M) on 2023-12-13, disclosed to the SEC on 2023-12-15.
Scheduled sale ($3.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.08 | 75,000 | $1.5M | 50.0% |
| 2 | $20.08 | 75,000 | $1.5M | 50.0% |
| Total | $20.08 avg | 150,000 | $3.0M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |